oral glp 1 drugs in development What is the pipeline for future medications for obesity? A new oral GLP-1 medication

Overall, 35% heard about compounded GLP-1 concerns

These rogue outfits should be avoided

The future of GLP-1 therapy isnt just about better metabolic outcomesits about delivering safer, more comprehensive care for diverse patient populations

Accessed 5 Oct 2020

25 Given concerns that skeletal muscle loss may predispose patients to long-term metabolic complications, including sarcopenia, it is recommended that individuals undergoing treatment with GLP-1 RAs receive adequate protein intake and appropriate micronutrient supplementation to preserve muscle mass and function, thereby maximizing the clinical benefits of therapy

MN: Continuing to focus on lifestyle habits can make a big difference, including working with a dietitian to make sure nutrition is well balanced, adding strength or weight training, improving sleep, managing stress, and reviewing whether any other medications could be contributing [to plateaus]